KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Staar Surgical (STAA) Net Income towards Common Stockholders (2016 - 2026)

Staar Surgical's Net Income towards Common Stockholders history spans 17 years, with the latest figure at $217000.0 for Q1 2026.

  • For Q1 2026, Net Income towards Common Stockholders fell 99.02% year-over-year to $217000.0; the TTM value through Jan 2026 reached -$61.9 million, down 270.86%, while the annual FY2026 figure was -$61.9 million, 270.86% down from the prior year.
  • Net Income towards Common Stockholders reached $217000.0 in Q1 2026 per STAA's latest filing, down from $8.9 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $57.4 million in Q4 2023 to a low of -$54.2 million in Q1 2025.
  • Average Net Income towards Common Stockholders over 5 years is $6.8 million, with a median of $8.1 million recorded in 2024.
  • Peak YoY movement for Net Income towards Common Stockholders: soared 365.56% in 2022, then crashed 1523.57% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $29.9 million in 2022, then surged by 92.16% to $57.4 million in 2023, then crashed by 61.29% to $22.2 million in 2024, then crashed by 60.02% to $8.9 million in 2025, then crashed by 97.56% to $217000.0 in 2026.
  • Per Business Quant, the three most recent readings for STAA's Net Income towards Common Stockholders are $217000.0 (Q1 2026), $8.9 million (Q3 2025), and -$16.8 million (Q2 2025).